Climbing above 4,000 meters can provoke abnormal heart rhythms in otherwise healthy mountaineers, with the abnormalities increasing with altitude, new research has shown.
Researchers supported by the National Institutes of Health have revealed the ability of wearable biosensors, similar to the Apple Watch or Fitbit, to detect physiological changes that may indicate illness, even before symptoms appear. The findings, published Jan. 12, 2017, in PLoS Biology, may open the door to new ways to manage and monitor health, especially for those with limited access to doctors or clinics.
More than 80 percent of stroke patients with a history of atrial fibrillation either received not enough or no anticoagulation therapy prior to having a stroke, according to a Duke Clinical Research Institute study. This revelation comes despite the drugs’ proven record of reducing stroke risk.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 14, 2017 — The United States Food and Drug Administration (FDA) has expanded use of the Medtronic Melody ...
March 14, 2017 — Transcatheter aortic valve replacement (TAVR) for aortic stenosis continues to evolve with the adoption ...
Stratasys Ltd. announced last week enrollment is now open for 3DHEART, an investigator-initiated trial. 3DHEART, which stands for 3D Hearts Enabling A Randomized Trial, is a randomized, single-blind clinical trial to study the use of patient-specific 3-D-printed models in pre-operative planning for pediatric heart surgery. Stratasys is providing in-kind support with printing of the models to be used in the trial.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
A new research study by the Harvey L. Neiman Health Policy Institute assesses relationships between county-level variation in Medicare beneficiary imaging resource consumption and measures of population economic status. The study, published online in the Journal of the American College of Radiology (JACR), found that in the Medicare population, imaging utilization and costs vary greatly at the county level, and far more than at the state level.
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently released new recommendations on procedures employing gadolinium-based contrast agents, in which the committee recommended suspension of marketing authorization for four agents.
The most prevalent method for obtaining images of clogged coronary vessels is coronary angiography. For some patients, however, the contrast agents used in this process can cause health problems. A team at the Technical University of Munich (TUM) has now demonstrated that the required quantity of these substances can be significantly reduced if monoenergetic X-rays from a miniature particle accelerator are used.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March, 10, 2017 - Medtronic announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved ...
Zoll Medical Corp. announced that the company’s Hospital Wearable Defibrillator (HWD) has been granted premarket approval (PMA) by the U.S. Food and Drug Administration (FDA) to market and begin U.S. distribution of the device.
Artificial intelligence (AI) has captured the imagination and attention of doctors over the past couple years as several ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Information technology (IT) is among the least sexy areas to cover in medical technology advances, and is often ...
ITN Editor Dave Fornell takes a tour of some of the most innovative new technology that was displayed on the expo floor ...
Metro Detroit cardiologists from five health systems have joined together to increase residents’ survival rate from heart attacks.